U.S. Facial Injectable Market Size, Share & Trends Analysis Report By Product (Botulinum Toxin Type A, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Facial Injectable Market Growth & Trends
The U.S. facial injectable market is anticipated to reach USD 8.02 billion by 2030, exhibiting a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing acceptance of aesthetic procedures and the increasing geriatric population are some of the major factors driving the market growth.
The increasing geriatric population of the U.S. is increasing the demand for the development of minimally invasive surgical procedures. Facial injectable offer an alternative to several aesthetic surgical procedures. Moreover, these procedures offer several advantages, such as less pain, less trauma, lesser blood loss, and faster recovery. In addition, the increasing focus of market players on developing demand-specific solutions with lesser allergy risk significantly contributes to the market growth.
The increasing awareness about aesthetic procedures owing to the rising focus on facial appearance further drives the market growth. Moreover, the availability of facial injectable to address different demands of patients has increased their demand in different age groups as per their needs. For instance, according to the 2022 Plastic Surgery Statistics Report of The American Society of Plastic Surgeons, the number of neuromodulator injection procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 70% and 74% from 2019 simultaneously. Similarly, the number of HA filler procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 69% and 70% from 2019 simultaneously. This increasing demand for facial injectable in different age groups is expected to drive market growth over the forecast period.
U.S. Facial Injectable Market Report Highlights
U.S. Facial Injectable Market Growth & Trends
The U.S. facial injectable market is anticipated to reach USD 8.02 billion by 2030, exhibiting a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing acceptance of aesthetic procedures and the increasing geriatric population are some of the major factors driving the market growth.
The increasing geriatric population of the U.S. is increasing the demand for the development of minimally invasive surgical procedures. Facial injectable offer an alternative to several aesthetic surgical procedures. Moreover, these procedures offer several advantages, such as less pain, less trauma, lesser blood loss, and faster recovery. In addition, the increasing focus of market players on developing demand-specific solutions with lesser allergy risk significantly contributes to the market growth.
The increasing awareness about aesthetic procedures owing to the rising focus on facial appearance further drives the market growth. Moreover, the availability of facial injectable to address different demands of patients has increased their demand in different age groups as per their needs. For instance, according to the 2022 Plastic Surgery Statistics Report of The American Society of Plastic Surgeons, the number of neuromodulator injection procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 70% and 74% from 2019 simultaneously. Similarly, the number of HA filler procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 69% and 70% from 2019 simultaneously. This increasing demand for facial injectable in different age groups is expected to drive market growth over the forecast period.
U.S. Facial Injectable Market Report Highlights
- Botulinum toxin type A dominated the product segment with a share of over 55% share in 2023 owing to its wide treatment, such as wrinkles, glabellar lines, lateral canthus, and others.
- The HA segment is expected to witness the fastest growth over the forecast period owing to the increasing focus of market players on developing hyaluronic fillers. The increasing demand for minimally invasive procedures and the surge in aesthetic procedures are driving the market growth.
- Some of the market players operating in the U.S. facial injectable market include AbbVie, Inc., REVANCE AESTHETICS, Merz North America, Inc., Galderma Laboratories, L.P., Suneva Medical Inc., Cytophil, Inc, and Prollenium Medical Technologies.
- In May 2023, Evolus, Inc. announced that the company had entered into an agreement with Symatese to be the distributor of five under-development derma fillers. This step significantly helped the company in expanding its product portfolio and taking a step towards becoming a multi-product aesthetic company.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. FACIAL INJECTABLE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing geriatric population
3.2.1.2. Rising awareness of aesthetic procedures
3.2.1.3. Increasing availability of innovative products
3.2.1.4. Rise in the number of aesthetic procedures performed
3.2.2. Market restraint analysis
3.2.2.1. Threat of side effects
3.3. U.S. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. FACIAL INJECTABLE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Facial Injectable Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Collagen & PMMA microspheres
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Botulinum toxin type A
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. HA
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. CaHA
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. PLLA
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. FACIAL INJECTABLE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Facial Injectable Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Facial line correction
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Lip augmentation
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Face lift
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Acne scar treatment
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Lipoatrophy treatment
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. FACIAL INJECTABLE MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Facial Injectable Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. MedSpa
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Dermatology clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Hospitals
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. FACIAL INJECTABLE MARKET: REGION ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Facial Injectable Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.3.2. Midwest
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. AbbVie, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. REVANCE AESTHETICS
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merz North America, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Galderma Laboratories, L.P.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Suneva Medical Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Cytophil, Inc
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Prollenium Medical Technologies.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. FACIAL INJECTABLE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing geriatric population
3.2.1.2. Rising awareness of aesthetic procedures
3.2.1.3. Increasing availability of innovative products
3.2.1.4. Rise in the number of aesthetic procedures performed
3.2.2. Market restraint analysis
3.2.2.1. Threat of side effects
3.3. U.S. Facial Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. FACIAL INJECTABLE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Facial Injectable Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Collagen & PMMA microspheres
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Botulinum toxin type A
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. HA
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. CaHA
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. PLLA
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. FACIAL INJECTABLE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Facial Injectable Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Facial line correction
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Lip augmentation
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Face lift
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Acne scar treatment
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Lipoatrophy treatment
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. FACIAL INJECTABLE MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Facial Injectable Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. MedSpa
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Dermatology clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Hospitals
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. FACIAL INJECTABLE MARKET: REGION ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Facial Injectable Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.3.2. Midwest
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. AbbVie, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. REVANCE AESTHETICS
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merz North America, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Galderma Laboratories, L.P.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Suneva Medical Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Cytophil, Inc
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Prollenium Medical Technologies.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. facial injectable market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. facial injectable market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. facial injectable market, by region, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. facial injectable market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. facial injectable market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. facial injectable market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. facial injectable market, by region, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. facial injectable market: market outlook
Fig. 9 U.S. facial injectable competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. facial injectable market driver impact
Fig. 14 U.S. facial injectable market restraint impact
Fig. 15 U.S. facial injectable market: Product movement analysis
Fig. 16 U.S. facial injectable market: Product outlook and key takeaways
Fig. 17 Collagen & PMMA microspheres market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Botulinum toxin type A market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 HA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 CaHA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 PLLA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. facial injectable market: Application movement Analysis
Fig. 24 U.S. facial injectable market: Application outlook and key takeaways
Fig. 25 Facial line correction market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Lip augmentation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Face lift market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Acne scar treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Lipoatrophy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. facial injectable market: End-use movement analysis
Fig. 32 U.S. facial injectable market: End-use outlook and key takeaways
Fig. 33 MedSpa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 U.S. facial injectable market: Regional movement analysis
Fig. 37 U.S. facial injectable market: Regional outlook and key takeaways
Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. facial injectable market: market outlook
Fig. 9 U.S. facial injectable competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. facial injectable market driver impact
Fig. 14 U.S. facial injectable market restraint impact
Fig. 15 U.S. facial injectable market: Product movement analysis
Fig. 16 U.S. facial injectable market: Product outlook and key takeaways
Fig. 17 Collagen & PMMA microspheres market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Botulinum toxin type A market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 HA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 CaHA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 PLLA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. facial injectable market: Application movement Analysis
Fig. 24 U.S. facial injectable market: Application outlook and key takeaways
Fig. 25 Facial line correction market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Lip augmentation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Face lift market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Acne scar treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Lipoatrophy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. facial injectable market: End-use movement analysis
Fig. 32 U.S. facial injectable market: End-use outlook and key takeaways
Fig. 33 MedSpa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 U.S. facial injectable market: Regional movement analysis
Fig. 37 U.S. facial injectable market: Regional outlook and key takeaways
Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
